Healthcare Global Market Report 2018 Including: Healthcare Services; Pharmaceutical Drugs; Medical Equipment; Biologics Covering: NHS, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG
Feb 2018
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Scope Markets Covered: Healthcare Services; Pharmaceutical Drugs; Medical Equipment; Biologics Companies Mentioned: NHS, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, Healthcare Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Healthcare Market Characteristics The healthcare industry is one of the largest and fast growing industries in the world, and it has a direct effect on the quality of life of patients. The term healthcare refers to diagnosis, treatment, and prevention of disease or illness, and other physical and mental impairments in humans and animals. The healthcare industry provides products and services to treat patients with curative, preventive, rehabilitative or palliative care. Healthcare products which mainly include drugs and medical equipment are manufactured by several companies and are approved by regulatory authorities. Healthcare services are delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, allied health, and other Access to healthcare varies across countries. It is largely influenced by social and economic conditions as well as the health policies. Each country has specific policies and plans in relation to the personal and population-based health care goals. According to World Health Organization (WHO), a well-functioning health care system requires a Healthcare industry in this report is segmented into healthcare services, pharmaceuticals drugs, medical equipment and biologics. Healthcare Services comprise hospitals, nursing and community care facilities; home healthcare services; medical and diagnostic laboratories; veterinary services and residential mental health centers. It also includes offices of Pharmaceuticals Drugs industry is comprised of many public and private organizations that discover, develop, manufacture and market medicines for human and animal health.
Pharmaceutical industry is largely driven by discovery and development of novel drugs. Drug manufactures rely on chemical manufacturers, bulk drug manufactures Medical Equipment market comprises surgical and medical instruments, surgical appliances and supplies, ophthalmic goods, dental laboratories, and in vitro Biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.
Healthcare Market Historic Growth The global healthcare market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global healthcare market during 2013 – 2017.
Drivers of the Market: The key drivers of the healthcare market during 2013 – 2017 included Health Insurance Reforms – Health insurance reforms have had a significant impact on the healthcare market growth in both developed and developing countries. The UK’s National Health Service went through a major reorganization after the introduction of the
Falling Oil Prices – The low price of oil in 2015 and 2016 improved the margins of companies operating in the plastics manufacturing market. Petrochemicals, plastics and other oil derivatives are important raw materials of Technology Development - Technological development was a key driver of the global economy during the historic period. Areas of rapid technological in the healthcare industry include robotics, IT, minimally invasive surgery technologies, Restraints on the Market: The key restraints on the healthcare market during 2013 – 2017 included Patent Expiration of Drugs – Most drugs are patented for a period after their launch during which time they can only be produced by the company that developed them. The dominance of generics past the expiration of Low Healthcare Access – Healthcare access was relatively poor in most developing countries compared to the developed nations. Globally, the disease burden is significantly Government Regulations – Complex clinical and regulatory standards have led to increased cost of product development and manufacturing. This coupled with rise in complexity and volume of medical
Healthcare Market Forecast Growth The global healthcare market is expected to grow from $XX billion in 2017 to $11801.7 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global healthcare market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:
Healthcare Market Segmentation The chart and table below shows the split of the healthcare market in 2017.
The total market value for healthcare was $X billion in 2017. The markets that are covered include Healthcare Services, Pharmaceutical Drugs, Medical Equipment, and Biologics. Healthcare Services was the x largest segment in the healthcare market with X% share of the market. The market value for the healthcare services was $x billion in 2017. Pharmaceutical Drugs made up around X% share of the market. The market value for the pharmaceutical drugs was $x billion in 2017.
Healthcare Market Regional And Country Analysis The Asia Pacific was the x largest region in the healthcare market in 2017, healthcare for $X billion or X% market share. North America was the x largest region healthcare for $X billion or X% market share. Europe was the x largest region healthcare for $X billion or X% market share.
Healthcare Market Competitive Landscape The leading competitors in the global healthcare market are NHS, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG. The chart and table below displays the percentage market share of the top players in the healthcare market industry.
NHS generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Johnson & Johnson generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Pfizer Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. F. Hoffmann-La Roche Ltd. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.
Novartis AG generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Sanofi S.A. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. GlaxosmithKline Plc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Gilead Sciences, Inc. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Medtronic generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Merck & Co. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year.
Company Profile National Health Service (NHS) Overview The UK’s National Health Service the largest company in the healthcare market in 2017 with a XX% share of the market. It is the publicly funded health care system created under the UK’s National Health Service Act. The organization was launched in 1948. It had more than XX million employees. Each of the four countries of the UK has a publicly funded health care system
•
NHS England
•
NHS Scotland
•
NHS Ireland
•
NHS Wales
The NHS hospitals provide extensive health care services and outpatient care. The primary services of NHS include antenatal screening, routine screenings, and treatment for long-term conditions include transplants, emergency treatment and end-of-life care.
Products and Services All the four healthcare systems are collectively referred to as the National Health Service, which employs more than XX million people. The NHS in England employs around XX million people. Of those, the clinically qualified staff include XX doctors, XX general practitioners, XX nurses and health visitors, XX ambulance staff, and XX hospital and community health service (HCHS) medical and dental staff.
Financial Performance Funding for the NHS comes directly from taxation. For 2015-16, the overall NHS budget was around GBP XX billion
Johnson & Johnson (J&J) Overview Products and Services Strategy Financial Performance
Pfizer Inc. Overview Products and Services Strategy Financial Performance
F. Hoffmann-La Roche Ltd Overview Products and Services Strategy Financial Performance
Novartis AG Overview Products and Services Strategy Financial Performance